English

Change in Optomed’s holding of treasury

Report this content

Optomed Plc Stock Exchange Release 18 February 2022 at 15.00, Helsinki

Change in Optomed’s holding of treasury

A total of 15,300 of shares have been subscribed for under the Company’s stock option plans 2017, 2017B and 2018C and Optomed has used treasury shares for the share subscriptions. The subscribed shares have been delivered to the subscribers on 18 February 2022.


The total amount of treasury shares is now 406,217.



Optomed Plc



Further enquiries

Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com

 

Optomed in Brief 

Optomed is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of various diseases, such as rapidly increasing diabetic retinopathy. Optomed has offices in Finland, the US and China and the company’s products are sold via various sales channels in over 60 countries globally

Subscribe